Covered recipient · General Payments record
MOHAMMED FERRAS DABBAGH
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2021–2024
$3,433.54
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,171.03 | 13 |
| Travel and Lodging | $578.97 | 4 |
| Education | $237.94 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Penumbra, Inc. | $741.70 | 4 |
| Abbott Laboratories | $414.18 | 2 |
| Medtronic, Inc. | $319.14 | 8 |
| ShockWave Medical, Inc | $282.50 | 2 |
| Edwards Lifesciences Corporation | $201.65 | 1 |
| ABIOMED | $28.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $237.94 | 03/07/2024 | Education | Undisputed | 01/23/2026 | 1125404289 | CMS |
| Abbott Laboratories | $176.24 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125002280 | CMS |
| ABIOMED | $28.77 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142261149 | CMS |
| Edwards Lifesciences Corporation | $201.65 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138820356 | CMS |
| Medtronic, Inc. | $19.53 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119278376 | CMS |
| Medtronic, Inc. | $11.88 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119278378 | CMS |
| Medtronic, Inc. | $1.56 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119278380 | CMS |
| Medtronic, Inc. | $125.58 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119278384 | CMS |
| Medtronic, Inc. | $46.08 | 03/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119278382 | CMS |
| Medtronic, Inc. | $60.12 | 03/25/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119278386 | CMS |
| Medtronic, Inc. | $38.90 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119278388 | CMS |
| Medtronic, Inc. | $15.49 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119278390 | CMS |
| Penumbra, Inc. | $120.17 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076230618 | CMS |
| Penumbra, Inc. | $186.67 | 04/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1076231230 | CMS |
| Penumbra, Inc. | $286.10 | 04/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1076232276 | CMS |
| Penumbra, Inc. | $148.76 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076210356 | CMS |
| ShockWave Medical, Inc | $124.74 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152979443 | CMS |
| ShockWave Medical, Inc | $157.76 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152978491 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.